Security key
501976104
Kyverna Therapeutics, Inc. - Common Stock (KYTX)
CUSIP: 501976104
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 28,136,737
- Total 13F value
- $138,294,516
- Share change
- -3,891,297
- Put/Call ratio
- 986%
- SEC-reported price per share
- $4.89
- Number of holders
- 92
- Value change
- -$28,965,516
- Number of buys
- 48
- Number of sells
- 43
- Shares outstanding
- 60,857,980
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
92
Top holders
10
KYTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Kyverna Therapeutics, Inc. SEC filings
Kyverna Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501976104
Recent filing periods:
Ownership snapshot
Top reported holders of KYTX - Kyverna Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vida Ventures Advisors, LLC
Disclosed value leader
Vida Ventures Advisors, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
Vida Ventures Advisors, LLC leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vida Ventures Advisors, LLC's linked filing trail.
Comparable ownership
Top 5
Vida Ventures Advisors, LLC
7.4%
Bain Capital Life Sciences Invest...
5.5%
Northpond Ventures, LLC
5.3%
JPMORGAN CHASE & CO
3.4%
DEERFIELD MANAGEMENT COMPANY, L.P.
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
Company
|
7.4%
|
$33,929,430
4,523,924 shares
|
— | 30 Jun 2024 |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
Company · 10%+ Owner
|
5.5%
|
$25,262,775
3,368,370 shares
|
— | 30 Jun 2024 |
| Northpond Ventures, LLC |
13F
Company
|
5.3%
|
$24,415,695
3,255,426 shares
|
— | 30 Jun 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
3.4%
|
$15,459,428
2,061,257 shares
|
— | 30 Jun 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
3.3%
|
$14,872,500
1,983,000 shares
|
— | 30 Jun 2024 |
| RTW INVESTMENTS, LP |
13F
Company
|
3%
|
$13,895,333
1,852,711 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
92
Shares
28,136,737
Rows available
92
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
87
Q3 2024 holders
92
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend